The technology, developed in part by the U.S. Department of Defense (DoD), examines vital signs and other biomarkers to predict the likelihood of infection up to 48 hours ahead of clinical suspicion, according to an article on the Healthcare IT News website.
The technology is intended for U.S. service members but expected to be used widely by civilians.
The healthcare technology company, Royal Philips, and the DoD collaborated on the 18-month project.
The technology is expected to be broadly applicable to civilian healthcare settings. It will eventually be used in scenarios where vital signs and biomarkers fluctuate, like during physical exertion and heat stress.
Disinfectant Contact Time: The Case for Biofilm Disruption
Rethinking How Healthcare Facilities Fund Construction Projects
Putting Trauma-Informed Design into Practice
Harris Health to Build New Freestanding Cancer Center
Inland Empire Health Plan Opens Expanded San Bernardino Community Wellness Center